Helsinki, Finland, September 04, 2016 --(PR.com
)-- Labsystems Diagnostics Oy, from Finland, a Trivitron Healthcare enterprise, has entered into a dealership relationship agreement with UK-based Oxford Biosystems for the UK and Ireland markets. With this engagement, Fabrizio Radice – LDx Global Sales & Mktg Director said, "I am proud that Oxford Biosystems will sell and support Labsystems Diagnostics products which will enhance Labsystems’ presence in the UK and Ireland markets for its Infectious Disease, Point of Care, PCR, Gastro and Newborn Screening products. The synergetic effect will provide better local support for end user laboratories, clinics, reference centers and large IVD portfolios."
The agreement will benefit Labsystems Diagnostics and Oxford Biosystems leverage their respective leadership and long term experience in respiratory infectious diseases like Chlamydia pneumoniae, Mycoplasma pneumoniae and Bordetella pertussis. Labsystems Diagnostics has long history of satisfied customers using company’s high quality EIA kits for laboratories. The company has also created unique Point-of Care tests for Mycoplasma pneumoniae and Chlamydia pneumoniae which allow the getting the results in 10 minutes from one fingertip blood drop. Labsystems Diagnostics is also a pioneer in the Newborn Screening (NBS), and was the first to develop fluorometric PKU (Phenylketonuria) test in microplate format. Company has recently created fully automated high-throughput platform for the NBS which facilitates testing of over 2000 babies’ samples in one run. Tests can also be combined, to run all the commonly used assays together. The Trivitron enterprise has an extensive R&D pipeline of over 35 products under development.
Mr. Mark Upton - Managing Director, Oxford Biosystems quoted - "Oxford Biosystems was established in 2001 with the aim of sourcing reliable, high quality in-vitro diagnostic products and research tools for clinical, industrial and research laboratories. Based in Milton Park, Oxfordshire, Oxford Biosystems offer a wide range of products incorporating a variety of technologies. Product specialists are trained in the application of the products and ensure that end-users are offered a highlevel of customer service and technical support."
Mrs. Fiona Alcock – Marketing Director, Oxford Biosystems quotes – "We are very pleased to be working with Labsystems Diagnstics Oy, a company with an excellent reputation for innovation and high quality products. The Labsystems range offers some exciting opportunities with some unique products and tests ideally suited for our demanding market. We are looking forward to introducing these products to our customers. Laboratories and hospitals will have a great benefit from the synergetic combination between the two companies’ expertise and strong technical and Sales support into the field."
About Trivitron Healthcare Labsystems Diagnostics:
Trivitron Healthcare is a globally acclaimed healthcare technology solution company headquartered in Chennai, India. Trivitron Healthcare strives to make healthcare technology accessible to all. Trivitron Healthcare offers solutions in laboratory medicine, Radiology, Radiology protection, Cardiology, OR, ICU, renal care, Newborn Screening.
Labsystems Diagnostics is proud to be part of the Trivitron group of companies since 2012. Labsystems has been a forerunner in innovative diagnostic research and development for over the last 30 years. Labsystems Diagnostics is committed to developing high quality diagnostic solutions for clinical and research laboratories, and for consumer use. The company is dedicated to R&D investment, with highly qualified personnel and state of the art production. A highly rigorous quality system and CE-marked products ensure sustainable quality of the products. These assets combined with efficient customer support have meant long term customer satisfaction and a solid reputation for success. Within 30 years of experience, Labsystems Diagnostics has been a key pioneer in IVD space and Newborn screening.
About Oxford Biosystems:
Based in Milton Park, Oxfordshire, Oxford Biosystems was established in 2001. In 2009 the company merged with Cadama Medical Ltd (founded in Birmingham, UK in 2002) bringing together experienced sales and marketing teams with expertise in a wide variety of technologies.
At the beginning of 2015 the majority shareholding of Oxford Biosystems was purchased by BioVendor – Laboratorni Medicina a.s, part of the BioVendor group with its own research, development and manufacturing capabilities. The BioVendor group of companies is composed of three divisions: Laboratory Medicine Division, Research and Diagnostic Products Division, and the Clinical Products Division which is itself made up of three companies – BioVendor Instruments a. s., Testline Clinical Diagnostics s. r. o., and Immunolab GmbH.
In addition to representing the BioVendor companies in the UK and Ireland, Oxford Biosystems is also proud to represent a number of other well respected international manufacturers. The continued success of the company is based on a combination of quality products, experienced and knowledgeable staff, and a high level of customer service.